logo80lv
Articlesclick_arrow
Professional Services
Research
Talentsclick_arrow
Events
Workshops
Aboutclick_arrow
Order outsourcing
Advertiseplayer
profile_loginLogIn

More Than 3M People Played A Plague Tale Requiem

Seizing the moment, Focus Entertainment announced a "renowned collaboration" with the developer on a new project.

Image credit: Asobo Studio, A Plague Tale: Requiem

In a recent post on Twitter, Focus Entertainment, the publisher of the stealth game A Plague Tale: Requiem, has shared that the number of players has surpassed three million. This milestone was reached 13 months after the game's official release.

"A heartfelt thank you to the 3 million players who embarked on the haunting journey of #APlagueTaleRequiem! Your support and passion mean everything to us," reads the statement on Twitter.

A Plague Tale: Requiem was released on October 17, and just 2 weeks after the initial launch the game surpassed over a million players. Today, with the game reaching over 3 million players who embarked on "a heartrending journey into a brutal, breathtaking world", we can see remarkable growth in the game's audience, with an additional two million players joining within a year.

The game has been warmly received, with an average score of 82 points on Metacritic, based on reviews from critics, and a score of 8.2 from users. On Steam, A Plague Tale: Requiem has a "very positive" review status, with over 91% positive comments.

To celebrate the figures, Focus Entertainment has also shared that it has resumed collaboration with Asobo Studio on "another exciting project". However, no specific details about this project have been revealed yet.

You can play the game on Steam and join our 80 Level Talent platform and our Telegram channel, follow us on InstagramTwitter, and LinkedIn, where we share breakdowns, the latest news, awesome artworks, and more.

Join discussion

Comments 0

    You might also like

    We need your consent

    We use cookies on this website to make your browsing experience better. By using the site you agree to our use of cookies.Learn more